Using tiny chambers that release signals from a patient’s own tumor, scientists trigger immune cells to mount a personalized attack against the cancer.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.